Red cell alloimmunization in a diverse population of transfused patients with thalassaemia
Open Access
- 17 February 2011
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 153 (1) , 121-128
Abstract
Summary: Red blood cell (RBC) transfusion is the primary treatment for severe forms of thalassaemia. Pre‐storage screening has resulted in decreased transfusion‐transmitted infections, but anti‐RBC antibodies remain a major problem. We report on 697 participants who had ever received transfusions. Allo‐ and autoantibody rates were compared with respect to splenectomy status, ethnicity, diagnosis, duration of transfusions, treatment centre, and age at transfusion initiation, together with rates before and after 1990, when leucoreduction methods were routine at thalassaemia treatment centres. Allo‐ and autoantibodies were reported in 115 (16·5%) and 34 (4·9%) subjects, respectively. Splenectomized patients were more likely to have alloantibodies [odds ratio (OR) = 2·528, P ≤ 0·0001], or autoantibodies (OR = 2·590, P = 0·0133). Alloantibodies occurred in 19 of 91 (21%) splenectomized subjects who started transfusion after 1990, and only 18 of 233 (7·7%) nonsplenectomized subjects (P < 0·001). Data from this study demonstrate that RBC antibodies continue to develop in chronically transfused thalassaemia patients at a high rate. Splenectomy preceded the development of antibodies in most cases. Increased rates of RBC sensitization among splenectomized patients is concerning and deserves further study.Keywords
This publication has 29 references indexed in Scilit:
- The Sickle Cell Sabbath: a community program increases first‐time blood donors in the African American faith communityTransfusion, 2009
- Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cellsBlood, 2007
- Blood Group Antibodies and Their Significance in Transfusion MedicineTransfusion Medicine Reviews, 2007
- Red blood cell alloantibodies after transfusion: factors influencing incidence and specificityTransfusion, 2005
- Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective studyBritish Journal of Haematology, 2005
- Complications of β-thalassemia major in North AmericaBlood, 2004
- A prospective study to determine the frequency and clinical significance of alloimmunization post‐transfusionBritish Journal of Haematology, 1995
- Problems in Transfusion TherapyNew England Journal of Medicine, 1990
- Alloimmunization in Sickle Cell Anemia and Transfusion of Racially Unmatched BloodNew England Journal of Medicine, 1990
- Chelation therapy in β-thalassemia major. III. The role of splenectomy in achieving iron balanceThe Journal of Pediatrics, 1981